Endovascular Today: Computational Model Suggests a New Paradigm for Accelerated Treatment Optimization With Paclitaxel Devices

August 28, 2019—CBSET announced that its scientists have published data and analyses that provide critical insights into the interplay between target anatomy and device attributes in determining balloon- and stent-based paclitaxel retention in healthy and diseased arteries. According to CBSET, these findings may transform the understanding of the safety and efficacy of paclitaxel-coated devices used in the treatment of peripheral artery disease.

The article, “Taking Paclitaxel Coated Balloons to a Higher Level: Predicting Coating Dissolution Kinetics, Tissue Retention and Dosing Dynamics,” by Abraham R. Tzafriri, PhD; Sahil A. Parikh, MD; and Elazer R. Edelman, MD, is available in Journal of Controlled Release (2019;310:94–102).

Read full article in Endovascular Today.